Minority interest volatility
Minority interest spiked to 38% of PAT in Q4 due to abnormal subsidiary profit; guided to normalize to ~25%, but could remain lumpy.
ENTERO / Q4-FY26 / risks
Keep the risk register visible.
Entero Healthcare Solutions · Material risks, their source context, and severity in the latest available quarter.
Research layer active
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Risk intelligence
Material risks this quarter
medium
Integration of recent acquisitions
Seven acquisitions closed in FY26, including three in medtech; integration risks and retention of key personnel are critical.
Interest cost headwinds
Finance costs rose as IPO funds were deployed; management expects stable near-term costs but sequential decline only over 2-3 years.
Dependence on IPM growth for organic outperformance
Organic growth multiplier vs IPM has compressed to ~1.4x from ~1.7x as IPM growth accelerated; any IPM slowdown could pressure organic growth.